Although annual breast magnetic resonance imaging (MRI) is recommended for women at high risk for breast cancer as an adjunct to screening mammography, breast MRI use remains low. We examined factors associated with breast MRI use in a cohort of women with a family history of breast cancer but no personal cancer history. Study participants came from the Sister Study cohort, a nationwide, prospective study of women with at least 1 sister who had been diagnosed with breast cancer but who themselves had not ever had breast cancer (n = 17 894).
| INTRODUCTION
Organizations such as the American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN) recommend annual breast magnetic resonance imaging (MRI) for women at high risk for breast cancer as an adjunct to mammography for screening, including those with a strong family history or who are known or likely carriers of a BRCA mutation. [1] [2] [3] [4] For women with known or suspected genetic mutations, the sensitivity of breast MRI with mammography is much higher than mammography alone. [5] [6] [7] However, research studies conducted after the 2007 ACS recommendation 1 have shown low use of breast MRI among women who might benefit from this test. [8] [9] [10] [11] [12] This analysis examines factors associated with breast MRI use among a cohort of women who had a first-degree family history of breast cancer (sister). After excluding women who had a personal history of cancer, except nonmelanoma skin cancer, we examined the relationship between ever having had a breast MRI and measures of breast cancer risk, sociodemographic characteristics, personal beliefs, and physician counseling.
| MATERIALS AND METHODS

The Centers for Disease Control and Prevention (CDC) and the NIH's National Institute of Environmental Health Sciences (NIEHS)
surveyed Sister Study participants on personal beliefs about breast cancer, cancer worry, breast MRI use, provider communication about familial breast cancer, genetic counseling and testing, and any available results of genetic testing. The Sister Study is a nationwide, prospective cohort study of women with at least 1 sister who had been diagnosed with breast cancer but who themselves had not ever had breast cancer. The Sister Study is described elsewhere (www.sis terstudy.niehs.nih.gov). 13, 14 The cohort has modestly elevated average risk and is composed of participants with a wide range of risk levels. At enrollment, all Sister Study participants completed computer-assisted telephone interviews and self-administered question- 
| Population
In 2011-2012, 21 189 Sister Study participants who had not reported having breast cancer were scheduled to complete the Annual Health Update and received the special survey. A total of 19 540 eligible participants completed the survey (participation rate = 92.2%). Age was measured as of the date of completing the survey. Women were excluded from the current analysis if they had been diagnosed with any cancer prior to this survey (n = 1367), had a history of lobular carcinoma in situ (n = 30), had undergone a prophylactic mastectomy (n = 78), or did not provide information on breast MRI (n = 171), resulting in 17 894 participants.
| MRI use
Women were given a brief description of a breast MRI and then asked whether they had ever had one. For only the most recent breast MRI, women were asked the reasons and could select more than 1 reason. Choices included "I had an abnormal mammogram"; "I had a lump or other breast problem"; "My healthcare provider told me I was at high risk"; "My family history of breast cancer"; "I have dense breasts"; or "I requested it." 
| Breast cancer risk
were then asked whether they had ever been told that they had a higher chance of getting breast cancer than other women of the same age. Responses to these 2 questions were combined to create a measure of communication: talked with doctor and was told of being at higher risk; talked with doctor and not told of being at higher risk; and did not talk with doctor about risk. Respondents also were asked whether a doctor or other health professional had ever recommended genetic counseling because of their family history and if they had undergone genetic counseling.
| Personal beliefs
Respondents were asked whether they perceived their lifetime risk of developing breast cancer to be much lower, lower, about the same, higher, or much higher than women their own age. They also reported that they strongly disagree, disagree, agree, or strongly agree with 3 statements related to worry about breast cancer and its effect on their lives: "I think about breast cancer more than most diseases"; "getting breast cancer is often in the back of my mind";
and "I am often bothered by thoughts or worry about my chances of getting breast cancer". Responses were scored from 1 for strongly disagree to 4 for strongly agree. The Cronbach coefficient standardized alpha for the responses to these last 3 questions was 0.84, indicating high internal item consistency or item homogeneity. 20 Responses were summed to create a composite measure of worry that reflected the distribution of the total scores: least worry (3-5); less worry (6); more worry (7-8); and most worry (9) (10) (11) (12) . Measures of worry were not calculated if responses to one or more of these 4
questions were missing (n = 356).
| Statistical analyses
Statistical analyses were performed with SAS, version 9.3. Logistic regression models were used to assess factors associated with ever or never having had a breast MRI for all participants and for women classified as at high risk, adjusted for demographic variables. The hot deck method 21 as implemented in SUDAAN was used to impute missing values for income (n = 646). Only age group and marital status were significant explanatory variables for missing income in a logistic regression and were used in the hotdeck procedure.
| RESULTS
Overall, 16.1% (n = 2885) reported having ever had a breast MRI for any reason. The demographic factors most strongly associated with breast MRI use were younger age (<50 years) and higher income (>$200 000) ( Table 1 ). All measures of breast cancer risk were positively associated with breast MRI use, and having a positive personal BRCA1 or BRCA2 test was by far the strongest determinant. Women who had talked with a doctor about their family history were more likely to have had a breast MRI, and this relationship was stronger for those who had been told they were at higher risk. Women who had received genetic counseling because of family history were much more likely to have received a breast MRI. Personal belief of being at higher risk and higher levels of worry also were associated with MRI use.
Using our criteria for high risk for breast cancer, 34% (n = 6078) of the women surveyed met one or more criteria. Of those, 88.8% had a BCRAT score of 20% or higher; 68.5% had two or more first-degree relatives with breast cancer; and 2.3% had a positive BRCA1 or BRCA2 test result. Only 10% (n = 616) of high-risk women met the criteria based only on the number of first-degree relatives with breast cancer.
The proportion of women who reported ever having had a breast MRI was substantially higher among the high-risk group compared to those not categorized as high risk (25.0% vs 11.6%, P < .01). Among the subset of women at high risk of breast cancer, the strongest associations with ever receiving a breast MRI were younger age, higher income, provider communication about family history, and genetic counseling ( Table 2 ). Perception of being at much higher risk of breast cancer and higher levels of worry also were associated with breast MRI use.
The reasons for the test were asked only for the most recent Although fairly low, these proportions were larger than the 4% and 10% reported among women at average and high risk of breast cancer, respectively, in the 2010 National Health Interview Survey, 8 perhaps reflecting the unique characteristics of this study population.
In addition to having a sister with breast cancer, women in the Sister
Study have, on average, higher levels of income, education, and insurance coverage than the general population. This may be especially relevant for obtaining a breast MRI, a procedure that requires justification and payment with varying coverage for the procedure across insurance companies.
In this population of cancer-free women, women who were told by a doctor that they had a higher risk of breast cancer were substantially more likely to report ever having had a breast MRI. These findings are consistent with those of a recent study reporting patients who received direct communications about their lifetime risk of breast cancer were more likely to receive adjunct breast MRI screening. 12 Women who perceived themselves at higher risk and those with higher worry levels also were more likely to have under- Although family history of breast cancer was self-reported, reporting of family history is generally considered accurate for first-degree relatives but possibly underreported for second degree relatives and paternal relatives. 23, 24 In addition to clinical and reproductive factors, the BRCAT model uses first-degree family history to estimate breast cancer risk and is not equivalent to other models that depend more on detailed family history. 25 However, this study included women whose sisters had breast cancer, and more than 3 quarters of the high-risk women in this study also met family history criteria for genetic counseling. Also, information on high-penetrance genetic factors such as BRCA1 and BRCA2 was incomplete, as testing remained expensive and was not done as part of the study. It is possible that some women with genetic mutations may not have been tested and therefore may not have been included among the high-risk women in this study.
Our study is the first to simultaneously examine the influence of 
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